Efficacy and safety of non–vitamin k antagonist oral anticoagulants in atrial fibrillation patients with impaired liver function: a retrospective cohort study
Background Patients with impaired liver function (ILF) were excluded from clinical trials that
investigated non–vitamin K antagonist oral anticoagulants (NOAC s) for stroke prevention in …
investigated non–vitamin K antagonist oral anticoagulants (NOAC s) for stroke prevention in …
Efficacy and safety of non–vitamin K antagonist oral anticoagulants in atrial fibrillation patients with impaired liver function: A retrospective cohort study
CL Wang, VCC Wu, CF Kuo, PH Chu… - Journal of the …, 2018 - pure.lib.cgu.edu.tw
Background-Patients with impaired liver function (ILF) were excluded from clinical trials that
investigated non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in …
investigated non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in …
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study
CL Wang, VCC Wu, CF Kuo, PH Chu… - Journal of the …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Patients with impaired liver function (ILF) were excluded from clinical trials that
investigated non-vitamin K antagonist oral anticoagulants (NOAC s) for stroke prevention in …
investigated non-vitamin K antagonist oral anticoagulants (NOAC s) for stroke prevention in …
Efficacy and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study
CL Wang, VCC Wu, CF Kuo, PH Chu, HJ Tseng… - 2018 - Am Heart Assoc
Background-—Patients with impaired liver function (ILF) were excluded from clinical trials
that investigated non–vitamin K antagonist oral anticoagulants (NOACs) for stroke …
that investigated non–vitamin K antagonist oral anticoagulants (NOACs) for stroke …
[PDF][PDF] Efficacy and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study
CL Wang, VCC Wu, CF Kuo, PH Chu, HJ Tseng… - 2018 - pdfs.semanticscholar.org
Background-—Patients with impaired liver function (ILF) were excluded from clinical trials
that investigated non–vitamin K antagonist oral anticoagulants (NOACs) for stroke …
that investigated non–vitamin K antagonist oral anticoagulants (NOACs) for stroke …
[PDF][PDF] Efficacy and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study
CL Wang, VCC Wu, CF Kuo, PH Chu, HJ Tseng… - 2018 - scholar.archive.org
Background-—Patients with impaired liver function (ILF) were excluded from clinical trials
that investigated non–vitamin K antagonist oral anticoagulants (NOACs) for stroke …
that investigated non–vitamin K antagonist oral anticoagulants (NOACs) for stroke …
[HTML][HTML] Efficacy and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study
CL Wang, VCC Wu, CF Kuo, PH Chu… - Journal of the …, 2018 - ncbi.nlm.nih.gov
Background Patients with impaired liver function (ILF) were excluded from clinical trials that
investigated non–vitamin K antagonist oral anticoagulants (NOAC s) for stroke prevention in …
investigated non–vitamin K antagonist oral anticoagulants (NOAC s) for stroke prevention in …
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study.
CL Wang, VC Wu, CF Kuo, PH Chu… - Journal of the …, 2018 - europepmc.org
Background Patients with impaired liver function (ILF) were excluded from clinical trials that
investigated non-vitamin K antagonist oral anticoagulants (NOAC s) for stroke prevention in …
investigated non-vitamin K antagonist oral anticoagulants (NOAC s) for stroke prevention in …
[PDF][PDF] Efficacy and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study
CL Wang, VCC Wu, CF Kuo, PH Chu, HJ Tseng… - 2018 - researchgate.net
Background-—Patients with impaired liver function (ILF) were excluded from clinical trials
that investigated non–vitamin K antagonist oral anticoagulants (NOACs) for stroke …
that investigated non–vitamin K antagonist oral anticoagulants (NOACs) for stroke …
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study.
CL Wang, VC Wu, CF Kuo, PH Chu… - Journal of the …, 2018 - europepmc.org
Background Patients with impaired liver function (ILF) were excluded from clinical trials that
investigated non-vitamin K antagonist oral anticoagulants (NOAC s) for stroke prevention in …
investigated non-vitamin K antagonist oral anticoagulants (NOAC s) for stroke prevention in …